Authors
Loading...
Randomized trial evaluates novel ferrocenyl derivatives for antiprotozoal activity against leishmaniasis and trypanosomiasis, indicating their potential as new treatments.
Saayman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: